179 related articles for article (PubMed ID: 37990282)
21. Evaluation of liver fluke recombinant cathepsin B-1 protease as a serodiagnostic antigen for human opisthorchiasis.
Sripa J; Brindley PJ; Sripa B; Loukas A; Kaewkes S; Laha T
Parasitol Int; 2012 Mar; 61(1):191-5. PubMed ID: 21704728
[TBL] [Abstract][Full Text] [Related]
22. Specific serum IgG, but not IgA, antibody against purified Opisthorchis viverrini antigen associated with hepatobiliary disease and cholangiocarcinoma.
Pinlaor P; Pongsamart P; Hongsrichan N; Sangka A; Srilunchang T; Mairiang E; Sithithaworn P; Pinlaor S
Parasitol Int; 2012 Mar; 61(1):212-6. PubMed ID: 21718798
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.
Lovis L; Mak TK; Phongluxa K; Ayé Soukhathammavong P; Vonghachack Y; Keiser J; Vounatsou P; Tanner M; Hatz C; Utzinger J; Odermatt P; Akkhavong K
PLoS Negl Trop Dis; 2012; 6(7):e1726. PubMed ID: 22848766
[TBL] [Abstract][Full Text] [Related]
24. Detection of Opisthorchis viverrini antigens in stools using specific monoclonal antibody.
Chaicumpa W; Ybanez L; Kitikoon V; Pungpak S; Ruangkunaporn Y; Chongsa-nguan M; Sornmani S
Int J Parasitol; 1992 Jul; 22(4):527-31. PubMed ID: 1644529
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a monoclonal antibody-based enzyme linked immunosorbent assay for the diagnosis of Opisthorchis viverrini infection in an endemic area.
Sirisinha S; Chawengkirttikul R; Haswell-Elkins MR; Elkins DB; Kaewkes S; Sithithaworn P
Am J Trop Med Hyg; 1995 Jun; 52(6):521-4. PubMed ID: 7611558
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta as a potential biomarker for
Prasopdee S; Yingchutrakul Y; Roytrakul S; Pholhelm M; Phanaksri T; Kunjantarachot A; Kulsantiwong J; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
Parasitology; 2022 Feb; 149(2):171-180. PubMed ID: 35234600
[TBL] [Abstract][Full Text] [Related]
27. Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand.
Saengsawang P; Promthet S; Bradshaw P
Asian Pac J Cancer Prev; 2013; 14(5):2963-6. PubMed ID: 23803062
[TBL] [Abstract][Full Text] [Related]
28. Detection of antibodies against Opisthorchis viverrini in patients before and after treatment with praziquantel.
Thammapalerd N; Tharavanij S; Nacapunchai D; Bunnag D; Radomyos P; Prasertsiriroj V
Southeast Asian J Trop Med Public Health; 1988 Mar; 19(1):101-8. PubMed ID: 3136551
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic values of parasite-specific antibody detections in saliva and urine in comparison with serum in opisthorchiasis.
Sawangsoda P; Sithithaworn J; Tesana S; Pinlaor S; Boonmars T; Mairiang E; Yongvanit P; Duenngai K; Sithithaworn P
Parasitol Int; 2012 Mar; 61(1):196-202. PubMed ID: 21704727
[TBL] [Abstract][Full Text] [Related]
30. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
[TBL] [Abstract][Full Text] [Related]
31. Opisthorchis viverrini infections and associated risk factors in a lowland area of Binh Dinh Province, Central Vietnam.
Dao TT; Bui TV; Abatih EN; Gabriël S; Nguyen TT; Huynh QH; Nguyen CV; Dorny P
Acta Trop; 2016 May; 157():151-7. PubMed ID: 26872984
[TBL] [Abstract][Full Text] [Related]
32. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Wangboon C; Yongvanit P; Loilome W; Thanan R; Worasith C; Eamudomkarn C; Chamadol N; Mairiang E; Sithithaworn J; Saichua P; Sripa B; Khuntikeo N; Bethony JM; Sithithaworn P
Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
[TBL] [Abstract][Full Text] [Related]
33. Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors.
Laoraksawong P; Sanpool O; Rodpai R; Thanchomnang T; Kanarkard W; Maleewong W; Kraiklang R; Intapan PM
BMC Public Health; 2018 Jul; 18(1):940. PubMed ID: 30064407
[TBL] [Abstract][Full Text] [Related]
34. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
Hanpanich P; Laha T; Sripa B; Mairiang E; Sereerak P; Upontain S; Tangkawattana P; Brindley PJ; Tangkawattana S
Parasitol Int; 2017 Aug; 66(4):464-470. PubMed ID: 27143606
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Opisthorchis viverrini infection among villagers harboring Opisthorchis-like eggs.
Sukontason KL; Sukontason K; Piangjai S; Pungpak S; Radomyos P
Southeast Asian J Trop Med Public Health; 2001; 32 Suppl 2():23-6. PubMed ID: 12041596
[TBL] [Abstract][Full Text] [Related]
36. Opisthorchis viverrini: evaluation of 28 kDa glutathione S-transferase as diagnostic tool in human opisthorchiasis.
Eursitthichai V; Viyanant V; Tesana S; Sithithaworn P; Kosa N; Grams R
Acta Trop; 2010 May; 114(2):76-80. PubMed ID: 20096257
[TBL] [Abstract][Full Text] [Related]
37. Opisthorchis viverrini: relationships between egg counts, worms recovered and antibody levels within an endemic community in northeast Thailand.
Elkins DB; Sithithaworn P; Haswell-Elkins M; Kaewkes S; Awacharagan P; Wongratanacheewin S
Parasitology; 1991 Apr; 102 Pt 2():283-8. PubMed ID: 1852494
[TBL] [Abstract][Full Text] [Related]
38. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
Mairiang E; Laha T; Kaewkes S; Loukas A; Bethony J; Brindley PJ; Sripa B
Acta Trop; 2021 May; 217():105853. PubMed ID: 33548204
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in the Diagnosis and Detection of Opisthorchis viverrini Sensu Lato in Human and Intermediate Hosts for Use in Control and Elimination Programs.
Saijuntha W; Duenngai K; Tangkawattana S; Petney TN; Andrews RH; Sithithaworn P
Adv Parasitol; 2018; 101():177-214. PubMed ID: 29907254
[TBL] [Abstract][Full Text] [Related]
40. Long-term Persistence of Opisthorchis viverrini Antigen in Urine: A Prospective Study in Northeast Thailand.
Worasith C; Wongphutorn P; Kopolrat KY; Homwong C; Techasen A; Thanan R; Wangboon C; Eamudomkarn C; Sithithaworn J; Crellen T; Sithithaworn P
Am J Trop Med Hyg; 2023 Feb; 108(2):356-358. PubMed ID: 36572008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
